دورية أكاديمية

Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.

التفاصيل البيبلوغرافية
العنوان: Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.
المؤلفون: Loutet MG, Davidson JA, Brown T, Dedicoat M, Thomas HL, Lalor MK
المصدر: Emerging infectious diseases [Emerg Infect Dis] 2018 Mar; Vol. 24 (3), pp. 524-533.
نوع المنشور: Historical Article; Journal Article
اللغة: English
بيانات الدورية: Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Atlanta, GA : National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), [1995-
مواضيع طبية MeSH: Antitubercular Agents/*pharmacology , Drug Resistance, Bacterial/*drug effects , Mycobacterium tuberculosis/*drug effects , Tuberculosis/*epidemiology, Adolescent ; Adult ; Antitubercular Agents/therapeutic use ; England/epidemiology ; Female ; History, 21st Century ; Humans ; Male ; Northern Ireland/epidemiology ; Retrospective Studies ; Tuberculosis/drug therapy ; Tuberculosis/history ; Tuberculosis/microbiology ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Multidrug-Resistant/epidemiology ; Tuberculosis, Multidrug-Resistant/history ; Tuberculosis, Multidrug-Resistant/microbiology ; Wales/epidemiology ; Young Adult
مستخلص: Among tuberculosis (TB) patients, acquired resistance to anti-TB drugs represents a failure in the treatment pathway. To improve diagnosis and care for patients with drug-resistant TB, we examined the epidemiology and risk factors associated with acquired drug resistance during 2000-2015 among TB patients in England, Wales, and Northern Ireland. We found acquired resistance in 0.2% (158/67,710) of patients with culture-confirmed TB. Using multivariate logistic regression, we identified the following factors associated with acquired drug resistance: having pulmonary disease; initial resistance to isoniazid, rifampin, or both; a previous TB episode; and being born in China or South Africa. Treatment outcomes were worse for patients with than without acquired resistance. Although acquired resistance is rare in the study area, certain patient groups are at higher risk. Identifying these patients and ensuring that adequate resources are available for treatment may prevent acquisition of resistance, thereby limiting transmission of drug-resistant strains of mycobacteria.
التعليقات: Comment in: Emerg Infect Dis. 2018 Nov;24(11):2134. (PMID: 30334732)
References: PLoS One. 2015 Aug 24;10(8):e0136179. (PMID: 26302242)
BMC Pulm Med. 2016 Feb 04;16:26. (PMID: 26846562)
Clin Infect Dis. 2014 Aug 15;59(4):465-72. (PMID: 24846639)
Lancet Infect Dis. 2015 Oct;15(10 ):1193-1202. (PMID: 26116186)
N Engl J Med. 1993 Sep 9;329(11):784-91. (PMID: 8350889)
Thorax. 2014 Oct;69(10):956-8. (PMID: 24334518)
Infect Dis Poverty. 2017 Jan 17;6(1):7. (PMID: 28093078)
PLoS One. 2016 Apr 07;11(4):e0152926. (PMID: 27055064)
J Clin Microbiol. 2006 Dec;44(12):4498-510. (PMID: 17005759)
PLoS One. 2013 Dec 23;8(12):e83006. (PMID: 24376623)
Clin Infect Dis. 2016 Feb 15;62(4):418-430. (PMID: 26508515)
Lancet Infect Dis. 2007 May;7(5):328-37. (PMID: 17448936)
J Infect Public Health. 2013 Dec;6(6):456-64. (PMID: 23999345)
Clin Infect Dis. 2008 Jan 1;46(1):42-9. (PMID: 18171212)
Clin Infect Dis. 2014 Oct 15;59(8):1049-63. (PMID: 25057101)
Emerg Infect Dis. 2015 Jun;21(6):1002-11. (PMID: 25988954)
Int J Tuberc Lung Dis. 2014 Oct;18(10):1180-7. (PMID: 25216831)
Clin Infect Dis. 2012 Dec;55(12):1600-7. (PMID: 22942206)
PLoS One. 2010 Dec 29;5(12):e15735. (PMID: 21209951)
Emerg Infect Dis. 2010 Feb;16(2):272-80. (PMID: 20113558)
Emerg Infect Dis. 2015 Jun;21(6):992-1001. (PMID: 25993036)
Int J Tuberc Lung Dis. 2010 Apr;14(4):382-90. (PMID: 20202293)
Emerg Infect Dis. 2011 Mar;17 (3):372-378. (PMID: 21392426)
Lancet. 2012 Oct 20;380(9851):1406-17. (PMID: 22938757)
Ther Adv Respir Dis. 2010 Apr;4(2):117-27. (PMID: 20388724)
Clin Infect Dis. 2007 Jun 1;44(11):1421-7. (PMID: 17479936)
J Infect. 2017 Mar;74(3):260-271. (PMID: 27998752)
PLoS One. 2016 Jan 14;11(1):e0146642. (PMID: 26765328)
فهرسة مساهمة: Keywords: England; Northern Ireland; TB; United Kingdom; Wales; acquired resistance; antimicrobial resistance; bacteria; drug resistance; tuberculosis and other mycobacteria
المشرفين على المادة: 0 (Antitubercular Agents)
تواريخ الأحداث: Date Created: 20180221 Date Completed: 20190116 Latest Revision: 20190116
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC5823342
DOI: 10.3201/eid2403.171362
PMID: 29460735
قاعدة البيانات: MEDLINE
الوصف
تدمد:1080-6059
DOI:10.3201/eid2403.171362